In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bioject bags $500,000 financing:

This article was originally published in Clinica

Executive Summary

Needle-free drug delivery company Bioject Medical Technologies has secured a $500,000 term loan from venture capital firm Partners for Growth (PFG). The loan is due in 12 equal monthly instalments and commences on October 1 2007. In return, PFG has a warrant to purchase around 71,000 Bioject shares at $1.40 per share. Portland, Oregon-based Bioject is currently developing a syringe for its approved product the Biojector 2000, which can deliver intramuscular or subcutaneous injections of up to 1mL in volume.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts